SCHEMBL3755939

SCHEMBL3755939

COc1c(C)c(C=C(C)C(=O)NCCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)c(OC)c(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.56
▸ ITGB1 P05556 1/20 0.49
▸ ITGA4 P13612 1/20 0.49
▸ PLCD1 P51178 1/20 0.49
▸ F2 P00734 1/20 0.48
▸ PRSS1 P07477 1/20 0.48
▸ PRSS2 P07478 1/20 0.48
▸ PRSS3 P35030 1/20 0.48
▸ TPSAB1 Q15661 1/20 0.48
▸ CA12 O43570 2/20 0.48
▸ CA1 P00915 2/20 0.48
▸ CA2 P00918 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ CNR1 P21554 3/20 0.48
▸ CAPN1 P07384 2/20 0.48
▸ FGF1 P05230 1/20 0.47
▸ FGF2 P09038 1/20 0.47
▸ VEGFA P15692 1/20 0.47
▸ HPSE Q9Y251 1/20 0.47
▸ CNR2 P34972 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3755935 1.00 TDP1 (0.56) TDP1ITGB1ITGA4PLCD1F2
SCHEMBL13049573 0.89 TDP1 (0.53) TDP1ITGB1ITGA4PLCD1F2
SCHEMBL16938350 0.89 TDP1 (0.53) TDP1ITGB1ITGA4PLCD1F2
SCHEMBL13079434 0.84 TDP1 (0.51) TDP1ITGB1ITGA4PLCD1CA12
SCHEMBL13049455 0.84 TDP1 (0.51) TDP1ITGB1ITGA4PLCD1CA12
SCHEMBL3755933 0.82 TDP1 (0.47) TDP1F2PRSS1PRSS2PRSS3
SCHEMBL13079659 0.82 TDP1 (0.48) TDP1TPSAB1
SCHEMBL18779801 0.80 TDP1 (0.78) TDP1ITGB1ITGA4PLCD1F2
SCHEMBL2768198 0.79 TDP1 (0.81) TDP1ITGB1ITGA4PLCD1F2
SCHEMBL18257192 0.79 TDP1 (0.81) TDP1ITGB1ITGA4PLCD1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203161-B1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF UNIV INDIANA RES & TECH CORP (US) 2018-05-09 — — EP disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 — — US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 TDP1 118/4885ITGB1 4691/4885ITGA4 4803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback